biosafety level 1

Deep research

Generated by just research-trait; source: research/traits/ecology/biosafety_level_1-deep-research-falcon.md

# Curation-focused research report: biosafety level 1

## Executive interpretation

**Trait:** biosafety level 1 (BSL-1), **METPO:1001102**, ecology class.

BSL-1 should be modeled primarily as a **protocol-level containment outcome**, not as a unitary microbial phenotype. It describes work with agents presenting minimal potential hazard, generally organisms not known to consistently cause disease in healthy immunocompetent adults, under standard microbiological practices. Risk Group 1 (RG1), by contrast, characterizes an agent’s intrinsic hazard. The containment assignment additionally depends on the manipulation, concentration and volume, aerosol or splash potential, exposure route, host range, genetic modifications, personnel, and available controls. ASM teaching guidance explicitly distinguishes risk group from biosafety level and illustrates that required containment changes with the procedure rather than following organism identity alone. (biosafety2013biosafetyguidelinesfor pages 1-2, gao2024frombiosafetyto pages 5-6)

Accordingly, a defensible TraitMech graph should have two linked layers:

1. **Agent-hazard layer:** limited pathogenicity, toxin production, adhesion/invasion, immune evasion, host colonization, persistence, antimicrobial resistance, and horizontal gene transfer.
2. **Protocol/control layer:** experimental operation, exposure generation, standard practices, physical containment, decontamination, and—where organisms are engineered—auxotrophy, kill switches, or genetic firewalls.

The graph should end in an intermediate node such as **“minimal assessed hazard under specified laboratory conditions”**, which supports BSL-1 assignment. It should not imply that any single gene deletion or safety circuit automatically makes an organism BSL-1.

## 1. Trait scope and boundaries

### Positive scope

The trait represents an **assay- and context-observed biorisk classification**: work can be conducted safely using basic laboratory facilities and standard microbiological practices because the combined agent and procedural risk is minimal. Typical BSL-1 settings include basic teaching and research laboratories. The recent historical review describes BSL-1 as applying to minimal/low-risk agents unlikely to cause disease in healthy adults, with general or standard practices. (gao2024frombiosafetyto pages 5-6)

### Nearby concepts that must remain separate

- **Risk Group 1:** an agent-hazard category; it is evidence feeding into—but not synonymous with—BSL-1.
- **Nonpathogenicity/avirulence:** microbial phenotypes that can lower hazard but do not determine containment independently.
- **GRAS or qualified-presumption-of-safety status:** food/regulatory safety concepts, not laboratory containment assignments.
- **Attenuation:** a strain-relative reduction in virulence; attenuated derivatives still require procedure-specific assessment.
- **Biocontainment:** engineered limitation of survival, replication, or gene flow. It can reduce risk but does not itself establish BSL-1.
- **BSL-2:** the next containment level, used for moderate-hazard agents or activities associated with human disease and additional exposure controls. (gao2024frombiosafetyto pages 5-6)

### Boundary cases

A nominally low-risk strain should not be assumed to remain BSL-1 when it contains an expressed toxin, virulence determinant, broad-host-range vector, clinically important resistance marker, or a modification increasing survival, host range, aerosol stability, or environmental persistence. Conversely, a strain with an auxotrophy or kill switch is not necessarily BSL-1 if its payload or procedure creates a moderate hazard. Host susceptibility is also a boundary: “not known to cause disease in healthy adults” does not mean incapable of opportunistic infection in immunocompromised persons.

## 2. Candidate nodes grouped by type

### Trait and assessment nodes

- **biosafety level 1** — METPO:1001102.
- **minimal assessed laboratory hazard** — label-only candidate.
- **risk-group classification** — label-only candidate.
- **protocol-specific microbial risk assessment** — label-only candidate.
- **worker exposure** and **environmental exposure** — label-only candidates.
- **containment escape frequency** — assay measurement; label-only candidate.

### Organisms and chassis

Use strain-level NCBITaxon identifiers only after confirming the exact strain record.

- *Escherichia coli* K-12 derivatives — model/industrial chassis; strain-specific.
- *Escherichia coli* Nissle 1917 — probiotic and therapeutic chassis; not interchangeable with K-12.
- *Lactococcus lactis* — food/therapeutic chassis.
- *Saccharomyces cerevisiae* — industrial and teaching yeast chassis.
- *Bacteroides thetaiotaomicron* and *B. ovatus* — engineered gut-therapeutic chassis; clinical context does not imply BSL-1 laboratory handling.
- Cyanobacterial and *Pseudomonas putida* synthetic-auxotrophy systems — taxon-specific experimental examples.

### Genes, proteins, and complexes

- **thyA / thymidylate synthase** — EC:2.1.1.45; deletion can create thymidine dependence.
- **dapA / 4-hydroxy-tetrahydrodipicolinate synthase** — EC:4.3.3.7; inactivation is used in diaminopimelate-dependent therapeutic strains.

Showing the first 60 of 230 lines of findings; the linked file also carries the run's front matter and the prompt it was given — read the full report.